MUHC offers immunocellular therapy for patients with leukemia or lymphoma | McGill University Health Centre
Treatment uses modified white blood cells to target cancer cells that are resistant to standard therapies.
Stay updated with breaking news from Stem Cell Transplant Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment uses modified white blood cells to target cancer cells that are resistant to standard therapies.
Dr. Koen van Besien will join University Hospitals Seidman Cancer Center on July 15 to lead the cellular therapy facility.
/PRNewswire/ -- One of America's top cancer doctors with a national and international reputation for cancer research will lead the new Wesley Center for...
/PRNewswire/ -- One of America's top cancer doctors with a national and international reputation for cancer research will lead the new Wesley Center for...
Lara Weberling could tell when her son Hans needed another blood transfusion during his battle against cancer. He would grow limp and exhausted, suffer severe nosebleeds and bruise easily. “When he go...